Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
46,993,375
-
Share change
-
+4,767,933
-
Total reported value
-
$3,114,104,096
-
Put/Call ratio
-
144%
-
Price per share
-
$66.29
-
Number of holders
-
226
-
Value change
-
+$342,475,956
-
Number of buys
-
117
-
Number of sells
-
80
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q3 2016
As of 30 Sep 2016,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
226 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,993,375 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, CITIGROUP INC, MORGAN STANLEY, BNP PARIBAS ARBITRAGE, SA, BANK OF AMERICA CORP /DE/, UBS Group AG, CREDIT SUISSE AG/, DISCOVERY CAPITAL MANAGEMENT, LLC / CT, WELLS FARGO & COMPANY/MN, and BARCLAYS PLC.
This page lists
227
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.